Abstract
The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well.
MeSH terms
-
Adult
-
Cause of Death
-
Colorectal Neoplasms / diagnosis*
-
Colorectal Neoplasms / mortality
-
Colorectal Neoplasms / prevention & control
-
Female
-
Humans
-
Lung Neoplasms / diagnosis*
-
Lung Neoplasms / mortality
-
Lung Neoplasms / prevention & control
-
Male
-
Mass Screening*
-
Middle Aged
-
Multicenter Studies as Topic
-
Ovarian Neoplasms / diagnosis*
-
Ovarian Neoplasms / mortality
-
Ovarian Neoplasms / prevention & control
-
Prostatic Neoplasms / diagnosis*
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / prevention & control
-
Randomized Controlled Trials as Topic*
-
Survival Analysis*
-
Treatment Outcome